Vident Advisory’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Buy |
1,881
+57
| +3% | +$7.16K | ﹤0.01% | 1422 |
|
|
2025
Q1 | $202K | Buy |
+1,824
| New | +$202K | ﹤0.01% | 1449 |
|
|
2024
Q3 | – | Sell |
-2,613
| Closed | -$360K | – | 1500 |
|
|
2024
Q2 | $360K | Sell |
2,613
-95,141
| -97% | -$13.1M | 0.01% | 1054 |
|
|
2024
Q1 | $13.5M | Buy |
97,754
+95,219
| +3,756% | +$13.1M | 0.28% | 134 |
|
|
2023
Q4 | $334K | Sell |
2,535
-152
| -6% | -$20K | 0.01% | 956 |
|
|
2023
Q3 | $302K | Buy |
+2,687
| New | +$302K | 0.01% | 898 |
|